ZY
Zhengye Biotechnology Holding Limited
ZYBT · NASDAQ
$1.55 +0.00% (+$0.00)
1M +2.58%
Market Cap ¥505.0M
P/E Ratio -
Div. Yield -
ROE 25.78%
Valuation
29 /100
Expensive P/S 4.34x
P/B 2.02x
P/FCF 718.37x
Growth
0 /100
Declining Rev. growth 23.53%
Book val. growth 5.55%
EPS growth N/A
Profitability
9 /100
Weak Gross margin 20.51%
Net margin 59.97%
FCF margin 0.60%
Quality
3 /100
Poor ROIC 20.63%
ROE 25.78%
Asset turnover 0.27x
Debt
57 /100
Moderate Debt/Equity 0.30x
Current ratio 1.14x
Int. coverage -20.14x
Stability
55 /100
Moderate Beta -2.53x
Rev. volatility 13.28%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ZYBT
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Songlin Song
Employees
269
Headquarters
Jilin